Evidence map›Paper›PMID 41536995›Full record

ReviewiScience2026

Magnesium metabolism: A potential breakthrough in osteoporosis intervention.

Wei Xiong, Yuxiang Zhou, Yilin Yan, Yuyi Li, Jingkun Li, Yifeng Yuan, Xiaolin Shi, Kang Liu

Abstract readReview
In one paragraph

Review in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wei XiongThe Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Yuxiang ZhouRehabilitation Department, Zhoushan Guanghua Hospital, Zhoushan, Zhejiang, China.
Yilin YanXinyu Traditional Chinese Medicine Hospital, Xinyu, Jiangxi, China.
Yuyi LiThe Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Jingkun LiThe Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Yifeng YuanThe Second Afffliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Xiaolin ShiThe Second Afffliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Kang LiuThe Second Afffliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis (OP), a multifactorial systemic skeletal disease, is characterized by significant reductions in bone density and quality, coupled with progressive deterioration of bone microarchitecture, and poses a significant health challenge. Conventional therapies, while partially effective, have limitations. Recent studies highlight the crucial role of magnesium (Mg) metabolism in bone health. Mg regulated bone homeostasis by promoting osteoblasts (OBs) differentiation and suppressing osteoclasts (OCs) activity. They also influence intracellular metabolism and hormonal functions. Mg deficiency can disrupt calcium (Ca) homeostasis, exacerbating bone resorption. Novel interventions, including Mg supplementation, Mg-based implants, offer promising approaches. This review synthesizes evidence on Mg's impact on OP pathogenesis and evaluates these therapeutic strategies, aiming to guide future research and clinical applications. It underscores Mg metabolic balance as a critical target for OP management.

Indexed as

Human metabolismTherapeutics

Identifiers

PMID41536995
PMCPMC12797042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.